Search Results - "du Bois, R"

Refine Results
  1. 1

    Strategies for treating idiopathic pulmonary fibrosis by du Bois, R. M

    Published in Nature reviews. Drug discovery (01-02-2010)
    “…Key Points Idiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial pneumonia (IIP), a group of diseases of unknown cause that…”
    Get full text
    Journal Article
  2. 2

    Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis by Zappala, C. J, Latsi, P. I, Nicholson, A. G, Colby, T. V, Cramer, D, Renzoni, E. A, Hansell, D. M, du Bois, R. M, Wells, A. U

    Published in The European respiratory journal (01-04-2010)
    “…In therapeutic studies in idiopathic pulmonary fibrosis (IPF), the low prevalence of significant change in pulmonary functional tests (PFTs) has been a major…”
    Get full text
    Journal Article
  3. 3

    Approaches to the treatment of some of the troublesome manifestations of sarcoidosis by Eklund, A., Bois, R. M.

    Published in Journal of internal medicine (01-04-2014)
    “…Sarcoidosis can be a major therapeutic challenge given its multiplicity of clinical presentations, variable combination of organ involvement and severity, and…”
    Get full text
    Journal Article
  4. 4

    Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis by Mukerjee, D., St. George, D., Knight, C., Davar, J., Wells, A. U., Du Bois, R. M., Black, C. M., Coghlan, J. G.

    Published in Rheumatology (Oxford, England) (01-04-2004)
    “…Objective. A prospective study to evaluate echocardiography and gas transfer (DLCO) by comparison with cardiac catheterization in discriminating between…”
    Get full text
    Journal Article
  5. 5

    Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis by Tansey, D, Wells, A U, Colby, T V, Ip, S, Nikolakoupolou, A, Du Bois, R M, Hansell, D M, Nicholson, A G

    Published in Histopathology (01-06-2004)
    “…Aims and methods:  Pulmonary parenchymal disease is common in patients with connective tissue disorders (CTDs). However, most reports precede recognition of…”
    Get full text
    Journal Article
  6. 6

    Genetics of fibrosing lung diseases by Grutters, J. C, du Bois, R. M

    Published in The European respiratory journal (01-05-2005)
    “…Genetic studies in familial lung fibrosis have demonstrated an association with surfactant protein C genes: two mutations have been found resulting in protein…”
    Get full text
    Journal Article
  7. 7

    Clinical response to morphine in cancer patients and genetic variation in candidate genes by Ross, J R, Rutter, D, Welsh, K, Joel, S P, Goller, K, Wells, A U, Du Bois, R, Riley, J

    Published in The pharmacogenomics journal (01-10-2005)
    “…Morphine is the analgesic of choice for moderate to severe cancer pain; however, 10-30% of patients do not tolerate morphine. This study evaluated genetic…”
    Get full text
    Journal Article
  8. 8

    Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF by Lawson, W E, Grant, S W, Ambrosini, V, Womble, K E, Dawson, E P, Lane, K B, Markin, C, Renzoni, E, Lympany, P, Thomas, A Q, Roldan, J, Scott, T A, Blackwell, T S, Phillips, J A, Loyd, J E, du Bois, R M

    Published in Thorax (01-11-2004)
    “…Background: While idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease, the aetiology of IPF is poorly understood…”
    Get full text
    Journal Article
  9. 9

    CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis by Sato, H, Williams, H. R. T, Spagnolo, P, Abdallah, A, Ahmad, T, Orchard, T. R, Copley, S. J, Desai, S. R, Wells, A. U, du Bois, R. M, Welsh, K. I

    Published in The European respiratory journal (01-02-2010)
    “…Sarcoidosis and Crohn's disease are heterogeneous systemic diseases characterised by granulomatous inflammation. Caspase recruitment domain (CARD)15 is a major…”
    Get full text
    Journal Article
  10. 10

    Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis by Beirne, P, Pantelidis, P, Charles, P, Wells, A. U, Abraham, D. J, Denton, C. P, Welsh, K. I, Shah, P. L, du Bois, R. M, Kelleher, P

    Published in The European respiratory journal (01-12-2009)
    “…Multiplex protein technology has the potential to identify biomarkers for the differentiation, classification and improved understanding of the pathogenesis of…”
    Get full text
    Journal Article
  11. 11

    T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis by KRIEGOVA, E, FILLEROVA, R, TOMANKOVA, T, HUTYROVA, B, MRAZEK, F, TICHY, T, KOLEK, V, DU BOIS, R. M, PETREK, M

    Published in The European respiratory journal (01-11-2011)
    “…Upregulation of genes for interferon (IFN)-γ and CXC chemokine receptor (CXCR)3 expression, two crucial molecules in sarcoid inflammation and granuloma…”
    Get full text
    Journal Article
  12. 12

    Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) by Raghu, G, King, T. E., Jr, Behr, J, Brown, K. K, du Bois, R. M, Leconte, I, Roux, S, Swigris, J

    Published in The European respiratory journal (01-01-2010)
    “…No therapy is known to improve health-related quality of life (HRQoL) or dyspnoea in patients with idiopathic pulmonary fibrosis. The present study…”
    Get full text
    Journal Article
  13. 13

    X‑ray Crystallographic Structure of a Teixobactin Derivative Reveals Amyloid-like Assembly by Yang, Hyunjun, Wierzbicki, Michał, Du Bois, Derek R, Nowick, James S

    Published in Journal of the American Chemical Society (31-10-2018)
    “…This paper describes the X-ray crystallographic structure of a derivative of the antibiotic teixobactin and shows that its supramolecular assembly through the…”
    Get full text
    Journal Article
  14. 14

    Increased epithelial permeability in pulmonary fibrosis in relation to disease progression by GOH, N. S. L, DESAI, S. R, ANAGNOSTOPOULOS, C, HANSELL, D. M, HOYLES, R. K, SATO, H, DENTON, C. P, BLACK, C. M, DU BOIS, R. M, WELLS, A. U

    Published in The European respiratory journal (01-07-2011)
    “…Epithelial injury contributes to pathogenesis in idiopathic pulmonary fibrosis (IPF) but its role in the interstitial lung disease (ILD) of systemic sclerosis…”
    Get full text
    Journal Article
  15. 15

    Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking by Craig, P J, Wells, A U, Doffman, S, Rassl, D, Colby, T V, Hansell, D M, Du Bois, R M, Nicholson, A G

    Published in Histopathology (01-09-2004)
    “…Aims : Respiratory bronchiolitis (RB) and desquamative interstitial pneumonia (DIP) are closely associated histological patterns of interstitial pneumonia,…”
    Get full text
    Journal Article
  16. 16

    Sarcoidosis by Baughman, Robert P, Lower, Elyse E, du Bois, Roland M

    Published in The Lancet (British edition) (29-03-2003)
    “…There have been several new insights into the cause and treatment of sarcoidosis. Studies of genetic variation have shown that specific genetic polymorphisms…”
    Get full text
    Journal Article
  17. 17

    A common haplotype of the C‐C chemokine receptor 2 gene and HLA‐DRB10301 are independent genetic risk factors for Löfgren’s syndrome by Spagnolo, P., Sato, H., Grunewald, J., Brynedal, B., Hillert, J., Mañá, J., Wells, A. U., Eklund, A., Welsh, K. I., Du Bois, R. M.

    Published in Journal of internal medicine (01-11-2008)
    “… Aim.  Sarcoidosis is a heterogeneous disorder with a strong genetic influence. Genetic factors are also thought to influence disease severity and outcome. We…”
    Get full text
    Journal Article
  18. 18

    Is there a role for microorganisms in the pathogenesis of sarcoidosis? by Du Bois, R. M., Goh, N., McGrath, D., Cullinan, P.

    Published in Journal of internal medicine (01-01-2003)
    “…  du Bois RM, Goh N, McGrath D, Cullinan P (Royal Brompton Hospital and Imperial College, London, UK). Is there a role for microorganisms in the pathogenesis…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia by Veeraraghavan, S, Latsi, P.I, Wells, A.U, Pantelidis, P, Nicholson, A.G, Colby, T.V, Haslam, P.L, Renzoni, E.A, du Bois, R.M

    Published in The European respiratory journal (01-08-2003)
    “…Idiopathic pulmonary fibrosis (IPF), which has the histological pattern of usual interstitial pneumonia (UIP), is a progressive interstitial lung disease with…”
    Get full text
    Journal Article
  20. 20

    Exercise peripheral oxygen saturation (SpO2) accurately reflects arterial oxygen saturation (SaO2) and predicts mortality in systemic sclerosis by Swigris, J J, Zhou, X, Wamboldt, F S, du Bois, R, Keith, R, Fischer, A, Cosgrove, G P, Frankel, S K, Curran-Everett, D, Brown, K K

    Published in Thorax (01-07-2009)
    “…Measures of oxygenation have not been assessed for prognostic significance in systemic sclerosis-related interstitial lung disease (SSc-ILD). 83 subjects with…”
    Get more information
    Journal Article